MEDICAMEN BIOTECH
Back to Balance Sheet
|
MEDICAMEN BIOTECH Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹294 Cr | ₹292 Cr | ₹277 Cr | ₹225 Cr | ₹194 Cr |
What is the latest Total Liabilities ratio of MEDICAMEN BIOTECH ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹294 Cr |
| Mar2024 | ₹292 Cr |
| Mar2023 | ₹277 Cr |
| Mar2022 | ₹225 Cr |
| Mar2021 | ₹194 Cr |
How is Total Liabilities of MEDICAMEN BIOTECH Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹294 Cr | 0.78 | |
| Mar2024 | ₹292 Cr | 5.57 | |
| Mar2023 | ₹277 Cr | 22.84 | |
| Mar2022 | ₹225 Cr | 16.08 | |
| Mar2021 | ₹194 Cr | - | |
Compare Total Liabilities of peers of MEDICAMEN BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MEDICAMEN BIOTECH | ₹440.0 Cr | 16.7% | 33.3% | -11.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,958.0 Cr | -3% | -5.2% | 17.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,576.0 Cr | 0.2% | 9.7% | 56.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,233.0 Cr | 1.3% | 2% | 36.5% | Stock Analytics | |
| CIPLA | ₹110,273.0 Cr | -2.2% | -6.6% | -10.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,906.4 Cr | 1.4% | -3.7% | -8.8% | Stock Analytics | |
MEDICAMEN BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MEDICAMEN BIOTECH | 16.7% |
33.3% |
-11.8% |
| SENSEX | -2.3% |
-4.1% |
-7.4% |
You may also like the below Video Courses